Please find attached herewith the disclosure regarding the Appointment of Mr. Narendra Bhandari as an Independent Director subject to the approval of shareholders of the company for the ....

August 11, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Plot no. C/1, G Block Mumbai – 400 001 Bandra Kurla Complex Bandra (East) Mumbai - 400 051 Scrip Code: 517562 Scrip ID: TRIGYN Company Code: TRIGYN Dear Sir / Madam, Subject: Outcome of the Meeting of the Board of Directors held on Tuesday, August 11, 2026 Pursuant to Regulations 30 and 33 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”), we wish to inform you that the Board of Directors of Trigyn Technologies Limited (“Company”), at its meeting held today, i.e. Tuesday, August 11, 2026, has, inter-alia, considered and approved the following matters: 1. APPROVAL OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2026 The Board of Directors, at its meeting held today, considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026, as reviewed and recommended by the Audit Committee at its meeting held earlier today, together with the respective Limited Review Reports issued by the Statutory Auditors of the Company, V. Rohatgi & Co., Chartered Accountants. The Unaudited Standalone and Consolidated Financial Results, along with the respective Limited Review Reports, are enclosed herewith The said Financial Results will also be made available on the Company’s website at www.trigyn.com and on the websites of BSE Limited and National Stock Exchange of India Limited and will be published in the newspapers in accordance with the applicable provisions of the SEBI Listing Regulations. 2. Appointment of Mr. Narendra Bhandari (DIN: 07501370) as an Independent Director, Subject to Approval of the Members Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors has approved the appointment of Mr. Narendra Bhandari (DIN: 07501370) as an Independent Director of the Company, subject to the approval of the Members of the Company, for a term of five consecutive years commencing from August 11, 2026 and ending on August 10, 2031. Trigyn Technologies Limited 27 SDF-1, SEEPZ, Andheri (East), Mumbai 400 096, India. Phone: +91-22-6140-0909 | Email: ro@trigyn.com www.trigyn.com | CIN: L72200MH1986PLC039341 The appointment is proposed to be placed before the Members of the Company for their approval at the ensuing 40th Annual General Meeting. Mr. Narendra Bhandari has furnished the requisite consent, declarations and confirmations in connection with his proposed appointment and has confirmed that he meets the criteria of independence prescribed under the Companies Act, 2013 and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. He has also confirmed that he is not debarred from holding the office of Director by virtue of any order of the Securities and Exchange Board of India or any other statutory authority. Regulation 30 of the SEBI Listing Regulations read with Schedule III thereto, are enclosed as Annexure A. The Board meeting commenced at 05:30 P.M. and concluded at 08.25 P.M. Request you to kindly acknowledge and take the above on record. Thanking You, For Trigyn Technologies Limited Anmol Chaturvedi Company Secretary & Compliance Officer Membership No. ACS 73871 Trigyn Technologies Limited 27 SDF-1, SEEPZ, Andheri (East), Mumbai 400 096, India. Phone: +91-22-6140-0909 | Email: ro@trigyn.com www.trigyn.com | CIN: L72200MH1986PLC039341 ANNEXURE A Details as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) read with Para A of Part A of Schedule III thereto and SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sr. No. Particulars Details 1. Name Mr. Narendra Bhandari 2. Reason for change viz. Appointment as an Independent Director of the appointment, re-appointment, Company, subject to approval of the Members of resignation, removal, death or the Company otherwise 3. Date of appointment/re- Approved by the Board with effect from August appointment/cessation (as 11, 2026, subject to the approval of the Members applicable) & term of of the Company, for a term of five consecutive appointment/re-appointment years commencing from August 11, 2026 and ending on August 10, 2031. 4. Brief Profile (in case of Mr. Narendra Bhandari is a technology and appointment) venture capital leader with over three decades of global experience across Intel, Microsoft, Persistent Systems and Soroco. He currently serves as General Partner at Seafund. His expertise includes enterprise technology, digital transformation, cloud, AI, SaaS and strategic partnerships. He holds a degree from IIT Madras and is a recipient of the Intel Achievement Award. 5. Disclosure of relationships Mr. Narendra Bhandari is not related to any of the between Directors (in case of Directors or Key Managerial Personnel of the appointment of a Director) Company. 6. Other Details Mr. Narendra Bhandari is not debarred from holding the office of director by virtue of any SEBI order or any other such authority. Trigyn Technologies Limited 27 SDF-1, SEEPZ, Andheri (East), Mumbai 400 096, India. Phone: +91-22-6140-0909 | Email: ro@trigyn.com www.trigyn.com | CIN: L72200MH1986PLC039341 #9, Shendge Avenue, 2ndFloor V.ROHATGI & CO. 2nd Street, K. Kamraja Road, Bangalore, 560042 Chartered Accountants e-mail: bipul@vrohatgi.com Independent Auditors’ Limited Review Report Review Report To The Board of Directors of Trigyn Technologies Limited, Independent Auditors’ Limited Review Report on Consolidated Unaudited quarterly and year-to-date Financial Results of Trigyn Technologies Limited for the quarter ended 30th June 2026 Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 1. We have reviewed the accompanying Statement of Unaudited Consolidated Financial Resultsof Trigyn Technologies Limited (“the Parent”) and its subsidiaries (the Parent and its subsidiaries together referred to as “the Group”), and its share of the net profit/(loss) after tax and total comprehensive income / loss of its associates and joint ventures for the quarter ended 30th June 2026 and for the period from 1stApril 2026to 30thJune 2026(“the Statement”), being submitted by the Parent pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 2. This statement, which is the responsibility of the Parent’s management and approved by Parent’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard for Interim Financial Reporting ("Ind AS-34"), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued there under and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the statement based on our review. 3. We conducted our review of the statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditors of the Entity" issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. [Showing first 8,000 characters — download PDF for full document]